Tesamorelin, like any medication, can cause side effects
Figure 5 displays individual rater scores and the combined score for each challenge
The comprehensive weight loss peptide guide compares semaglutide against every other option in detail
In a placebo-controlled trial, weekly subcutaneous semaglutide led to larger reductions in BMI (16.1% with semaglutide and +0.6% with placebo), body weight (15.3 kg with semaglutide and +2.4 kg with placebo), waist circumference, glycated hemoglobin levels, lipid parameters (excluding HDL), and alanine aminotransferase at 68 weeks versus placebo [14]
It also seems to work well for spinal cord injuries with TBI, and for concussions in conjunction with BPC-157, as well as for ischemic stroke, corneal injuries, and lung inflammation
These findings suggest that the GCGR agonism of Retatrutide contributes to the reduction in circulating ANGPTL3/8, which in turn may lead to lower triglyceride and LDL-cholesterol levels